Search research articles
Contact Us
Filters
Showing results (61-70 of 81) with videos related to
Page
of 9
Sort By:
Biomacromolecules
|
April 30, 2010
Well-defined poly(2-hydroxyl-3-(2-hydroxyethylamino)propyl methacrylate) vectors with low toxicity and high gene transfection efficiency
F J Xu, M Y Chai, W B Li, et al.
Bioconjugate Chemistry
|
September 22, 2010
Bifunctional conjugates comprising β-cyclodextrin, polyethylenimine, and 5-fluoro-2'- deoxyuridine for drug delivery and gene transfer
X Lu, Y Ping, F J Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 1998
Cell surface density of p185(c-erbB-2) determines susceptibility to anti-p185(c-erbB-2)-ricin A chain (RTA) immunotoxin therapy alone and in combination with anti-p170(EGFR)-RTA in ovarian cancer cells
G S Dean, L Pusztai, F J Xu, et al.
Nuclear Medicine and Biology
|
January 11, 2000
Radioiodinated antibody targeting of the HER-2/neu oncoprotein: effects of labeling method on cellular processing and tissue distribution
M R Zalutsky, F J Xu, Y Yu, et al.
Biomaterials
|
April 4, 2012
A gene nanocomplex conjugated with monoclonal antibodies for targeted therapy of hepatocellular carcinoma
J L Wang, G P Tang, J Shen, et al.
Gynecologic Oncology
|
August 12, 1998
Suppression of diacylglycerol levels by antibodies reactive with the c-erbB-2 (HER-2/neu) gene product p185c-erbB-2 in breast and ovarian cancer cell lines
M P Boente, A Berchuck, R S Whitaker, et al.
American Journal of Obstetrics and Gynecology
|
December 11, 1992
The effect of interferon gamma on epidermal growth factor receptor expression in normal and malignant ovarian epithelial cells
M P Boente, A Berchuck, G C Rodriguez, et al.
Nuclear Medicine and Biology
|
July 1, 1997
Radioiodinated antibody targeting of the HER-2/neu oncoprotein
F J Xu, Y H Yu, D S Bae, et al.
Biomaterials
|
January 10, 2013
Cationic microRNA-delivering nanovectors with bifunctional peptides for efficient treatment of PANC-1 xenograft model
Q L Hu, Q Y Jiang, X Jin, et al.
International Journal of Cancer
|
October 15, 1994
The tyrosine kinase activity of the C-erbB-2 gene product (p185) is required for growth inhibition by anti-p185 antibodies but not for the cytotoxicity of an anti-p185-ricin-A chain immunotoxin
F J Xu, C M Boyer, D S Bae, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 81) with videos related to
Sort By:
Page
of 9
Biomacromolecules
|
April 30, 2010
Well-defined poly(2-hydroxyl-3-(2-hydroxyethylamino)propyl methacrylate) vectors with low toxicity and high gene transfection efficiency
F J Xu, M Y Chai, W B Li, et al.
Bioconjugate Chemistry
|
September 22, 2010
Bifunctional conjugates comprising β-cyclodextrin, polyethylenimine, and 5-fluoro-2'- deoxyuridine for drug delivery and gene transfer
X Lu, Y Ping, F J Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 1998
Cell surface density of p185(c-erbB-2) determines susceptibility to anti-p185(c-erbB-2)-ricin A chain (RTA) immunotoxin therapy alone and in combination with anti-p170(EGFR)-RTA in ovarian cancer cells
G S Dean, L Pusztai, F J Xu, et al.
Nuclear Medicine and Biology
|
January 11, 2000
Radioiodinated antibody targeting of the HER-2/neu oncoprotein: effects of labeling method on cellular processing and tissue distribution
M R Zalutsky, F J Xu, Y Yu, et al.
Biomaterials
|
April 4, 2012
A gene nanocomplex conjugated with monoclonal antibodies for targeted therapy of hepatocellular carcinoma
J L Wang, G P Tang, J Shen, et al.
Gynecologic Oncology
|
August 12, 1998
Suppression of diacylglycerol levels by antibodies reactive with the c-erbB-2 (HER-2/neu) gene product p185c-erbB-2 in breast and ovarian cancer cell lines
M P Boente, A Berchuck, R S Whitaker, et al.
American Journal of Obstetrics and Gynecology
|
December 11, 1992
The effect of interferon gamma on epidermal growth factor receptor expression in normal and malignant ovarian epithelial cells
M P Boente, A Berchuck, G C Rodriguez, et al.
Nuclear Medicine and Biology
|
July 1, 1997
Radioiodinated antibody targeting of the HER-2/neu oncoprotein
F J Xu, Y H Yu, D S Bae, et al.
Biomaterials
|
January 10, 2013
Cationic microRNA-delivering nanovectors with bifunctional peptides for efficient treatment of PANC-1 xenograft model
Q L Hu, Q Y Jiang, X Jin, et al.
International Journal of Cancer
|
October 15, 1994
The tyrosine kinase activity of the C-erbB-2 gene product (p185) is required for growth inhibition by anti-p185 antibodies but not for the cytotoxicity of an anti-p185-ricin-A chain immunotoxin
F J Xu, C M Boyer, D S Bae, et al.
Page
of 9